The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NRG Oncology/NSABP B-31: Stromal tumor infiltrating lymphocytes (sTILs) and outcomes in early-stage HER2-positive breast cancer (BC).
 
Rim S. Kim
No Relationships to Disclose
 
Nan Song
Patents, Royalties, Other Intellectual Property - The following patent was filed Patent Application Serial No. 14/738,757 entitled “Methods of Subtyping CRC and their Association with Treatment of Colon Cancer Patients with Oxaliplatin and published on 12/24/15
 
Patrick G. Gavin
No Relationships to Disclose
 
Roberto Salgado
Travel, Accommodations, Expenses - Roche; Roche
 
Hanna Bandos
No Relationships to Disclose
 
Zuzana Kos
No Relationships to Disclose
 
Giuseppe Floris
No Relationships to Disclose
 
Gert G. Van den Eynden
Travel, Accommodations, Expenses - Roche
 
Sunil S. Badve
No Relationships to Disclose
 
Priya Rastogi
No Relationships to Disclose
 
Louis Fehrenbacher
Research Funding - Roche/Genentech (Inst)
 
Eleftherios P. Mamounas
Honoraria - Genentech/Roche; Genomic Health
Consulting or Advisory Role - bioTheranostics; Celcuity; Genomic Health; GRAIL; Macrogenics
Speakers' Bureau - Genentech/Roche; Genomic Health
Travel, Accommodations, Expenses - Celgene; Genentech/Roche; Genomic Health
 
Sandra M. Swain
Honoraria - Novartis; Roche
Consulting or Advisory Role - Genentech/Roche; Inivata; Lilly; Pieris Pharmaceuticals
Research Funding - Genentech (Inst); Lilly (Inst); Merrimack; Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Caris Centers of Excellence; Genentech/Roche; Inivata
Other Relationship - AstraZeneca
 
Donald Lawrence Wickerham
No Relationships to Disclose
 
Peter C. Lucas
Stock and Other Ownership Interests - Amgen
 
Joseph P. Costantino
Consulting or Advisory Role - Pfizer
 
Charles E. Geyer
Consulting or Advisory Role - Celgene; HERON; Myriad Genetics
Research Funding - Merck
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Genentech/Roche
 
Norman Wolmark
Research Funding - AbbVie (Inst); AbbVie (Inst); Bayer (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Puma Biotechnology (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - AbbVie (Inst)
Travel, Accommodations, Expenses - Abbvie; AbbVie; Genentech; GHI Pharma; Sanofi
 
Soonmyung Paik
No Relationships to Disclose
 
Katherine L. Pogue-Geile
Patents, Royalties, Other Intellectual Property - The following patent was submitted: U. S. Patent Application Serial No. 14/738,757, entitled: “Methods of Subtyping CRC and their Association with Treatment of Colon Cancer Patients with Oxaliplatin." Published 12/24/15.